Violetta Cotreau - May 12, 2022 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, Chief Accounting Officer
Signature
/s/ Carolyn Rucci, attorney-in-fact for Violetta Cotreau
Stock symbol
AKBA
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
5/16/2022, 04:04 PM
Previous filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Award $0 +150K +214.43% $0.00 220K May 12, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.